Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100420.ABSTRACTData on effectiveness of the BioNTech-/Pfizer COVID-19 vaccine in real-world settings are limited. In a study of 6,423 healthcare workers in Treviso Province, Italy, we estimated that, within the time intervals of 14-21 days from the first and at least 7 days from the second dose, vaccine effectiveness in preventing SARS-CoV-2 infection was 84% (95% confidence interval (CI): 40-96) and 95% (95% CI: 62-99), respectively. These results could support the ongoing vaccination campaigns by providing evidence for targeted communication.PMID:33928...
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Massimo Fabiani Mauro Ramigni Valentina Gobbetto Alberto Mateo-Urdiales Patrizio Pezzotti Cinzia Piovesan Source Type: research

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
We described existing programmes and used multivariable regression to identify independent factors associated with having them.ResultsOf 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and> 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sarah R Williams Amanda J Driscoll Hanna M LeBuhn Wilbur H Chen Kathleen M Neuzil Justin R Ortiz Source Type: research

Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
ConclusionThe immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW's immune status in order to identify those who would benefit from vaccination.PMID:33928900 | DOI:10.2807/1560-7917.ES.2021.26.17.2001167 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Marie-Louise von Linstow Alex Yde Nielsen Nikolai Kirkby Anna Eltvedt Thilde Nordmann Winther Allan Bybeck Nielsen Didi Bang Anja Poulsen Source Type: research

No country or continent is on its own in the ongoing COVID-19 pandemic
Euro Surveill. 2021 Apr;26(17). doi: 10.2807/1560-7917.ES.2021.26.17.2100430.NO ABSTRACTPMID:33928901 | DOI:10.2807/1560-7917.ES.2021.26.17.2100430 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Kari Johansen Hanna Nohynek Source Type: research

Socioeconomic deprivation is inversely associated with measles incidence:  a longitudinal small-area analysis, Germany, 2001 to 2017
ConclusionSocioeconomic deprivation in Germany, one of Europe's most populated countries, is inversely associated with measles incidence. This association persists after demographic and spatiotemporal factors are considered. The social, spatial and temporal patterns of elevated risk require targeted public health action and policy to address the complexity underlying measles epidemiology.PMID:33928902 | DOI:10.2807/1560-7917.ES.2021.26.17.1900755 (Source: Euro Surveill)
Source: Euro Surveill - April 30, 2021 Category: Infectious Diseases Authors: Sven Rohleder Christian Stock Kayvan Bozorgmehr Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16):2100348. doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | PMC:PM...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16):2104221. doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | PMC:PMC8063587 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16):2100413. doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16):2100348. doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | PMC:PM...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16):2104221. doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | PMC:PMC8063587 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16):2100413. doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.ABSTRACTWe compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).PMID:33890566 | DOI:10.2807/15...
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Tjede Funk Anastasia Pharris Gianfranco Spiteri Nick Bundle Angeliki Melidou Michael Carr Gabriel Gonzalez Alejandro Garcia-Leon Fiona Crispie Lois O'Connor Niamh Murphy Jo ël Mossong Anne Vergison Anke K Wienecke-Baldacchino Tamir Abdelrahman Flavia Ric Source Type: research

Job vacancy at the European Centre for Disease Prevention and Control (ECDC)
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2104221.NO ABSTRACTPMID:33890567 | DOI:10.2807/1560-7917.ES.2021.26.16.2104221 (Source: Euro Surveill)
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100413.ABSTRACTSARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B....
Source: Euro Surveill - April 23, 2021 Category: Infectious Diseases Authors: Sabrina Jungnick Bernhard Hobmaier Lena Mautner Mona Hoyos Maren Haase Armin Baiker Heidi Lahne Ute Eberle Clara Wimmer Sabrina Hepner Annika Sprenger Carola Berger Alexandra Dangel Manfred Wildner Bernhard Liebl Nikolaus Ackermann Andreas Sing Volker Fin Source Type: research

Correction for Euro Surveill. 2020;26(11)
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.210415c.NO ABSTRACTPMID:33860746 | DOI:10.2807/1560-7917.ES.2021.26.15.210415c (Source: Euro Surveill)
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.2001695.ABSTRACTBackgroundChildren's role in SARS-CoV-2 epidemiology remains unclear. We investigated an initially unnoticed SARS-CoV-2 outbreak linked to schools in northern France, beginning as early as mid-January 2020.AimsThis retrospective observational study documents the extent of SARS-CoV-2 transmission, linked to an affected high school (n = 664 participants) and primary schools (n = 1,340 study participants), in the context of unsuspected SARS-CoV-2 circulation and limited control measures.MethodsBetween 30 March and 30 April 2020, all school st...
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Arnaud Fontanet Laura Tondeur Rebecca Grant Sarah Temmam Yoann Madec Thomas Bigot Ludivine Grzelak Isabelle Cailleau Camille Besombes Marie-No ëlle Ungeheuer Charlotte Renaudat Blanca Liliana Perlaza Laurence Arowas Nathalie Jolly Sandrine Fernandes Pell Source Type: research

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.2100272.ABSTRACTFollowing the spread of the SARS-CoV-2 B.1.1.7 variant, social distancing was strengthened in France in January 2021. Using a two-strain mathematical model calibrated on genomic surveillance, we estimated that curfew measures allowed hospitalisations to plateau by decreasing transmission of the historical strains while B.1.1.7 continued to grow. School holidays appear to have further slowed down progression in February. Without progressively strengthened social distancing, a rapid surge of hospitalisations is expected, despite the foreseen...
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Laura Di Domenico Chiara E Sabbatini Giulia Pullano Daniel L évy-Bruhl Vittoria Colizza Source Type: research

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
ConclusionsIn a first continuous surveillance of CPE in Switzerland, we found that the epidemiological situation aggravated nationwide and that regional patterns of CPE genotypes mirrored the situation in neighbouring European countries.PMID:33860749 | DOI:10.2807/1560-7917.ES.2021.26.15.1900760 (Source: Euro Surveill)
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Alban Ramette Michael Gasser Patrice Nordmann Reinhard Zbinden Jacques Schrenzel Damir Perisa Andreas Kronenberg Source Type: research

Correction for Euro Surveill. 2020;26(11)
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.210415c.NO ABSTRACTPMID:33860746 | DOI:10.2807/1560-7917.ES.2021.26.15.210415c (Source: Euro Surveill)
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.2001695.ABSTRACTBackgroundChildren's role in SARS-CoV-2 epidemiology remains unclear. We investigated an initially unnoticed SARS-CoV-2 outbreak linked to schools in northern France, beginning as early as mid-January 2020.AimsThis retrospective observational study documents the extent of SARS-CoV-2 transmission, linked to an affected high school (n = 664 participants) and primary schools (n = 1,340 study participants), in the context of unsuspected SARS-CoV-2 circulation and limited control measures.MethodsBetween 30 March and 30 April 2020, all school st...
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Arnaud Fontanet Laura Tondeur Rebecca Grant Sarah Temmam Yoann Madec Thomas Bigot Ludivine Grzelak Isabelle Cailleau Camille Besombes Marie-No ëlle Ungeheuer Charlotte Renaudat Blanca Liliana Perlaza Laurence Arowas Nathalie Jolly Sandrine Fernandes Pell Source Type: research

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.2100272.ABSTRACTFollowing the spread of the SARS-CoV-2 B.1.1.7 variant, social distancing was strengthened in France in January 2021. Using a two-strain mathematical model calibrated on genomic surveillance, we estimated that curfew measures allowed hospitalisations to plateau by decreasing transmission of the historical strains while B.1.1.7 continued to grow. School holidays appear to have further slowed down progression in February. Without progressively strengthened social distancing, a rapid surge of hospitalisations is expected, despite the foreseen...
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Laura Di Domenico Chiara E Sabbatini Giulia Pullano Daniel L évy-Bruhl Vittoria Colizza Source Type: research

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
ConclusionsIn a first continuous surveillance of CPE in Switzerland, we found that the epidemiological situation aggravated nationwide and that regional patterns of CPE genotypes mirrored the situation in neighbouring European countries.PMID:33860749 | DOI:10.2807/1560-7917.ES.2021.26.15.1900760 (Source: Euro Surveill)
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Alban Ramette Michael Gasser Patrice Nordmann Reinhard Zbinden Jacques Schrenzel Damir Perisa Andreas Kronenberg Source Type: research

Correction for Euro Surveill. 2020;26(11)
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.210415c.NO ABSTRACTPMID:33860746 | DOI:10.2807/1560-7917.ES.2021.26.15.210415c (Source: Euro Surveill)
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Eurosurveillance editorial team Source Type: research

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.2001695.ABSTRACTBackgroundChildren's role in SARS-CoV-2 epidemiology remains unclear. We investigated an initially unnoticed SARS-CoV-2 outbreak linked to schools in northern France, beginning as early as mid-January 2020.AimsThis retrospective observational study documents the extent of SARS-CoV-2 transmission, linked to an affected high school (n = 664 participants) and primary schools (n = 1,340 study participants), in the context of unsuspected SARS-CoV-2 circulation and limited control measures.MethodsBetween 30 March and 30 April 2020, all school st...
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Arnaud Fontanet Laura Tondeur Rebecca Grant Sarah Temmam Yoann Madec Thomas Bigot Ludivine Grzelak Isabelle Cailleau Camille Besombes Marie-No ëlle Ungeheuer Charlotte Renaudat Blanca Liliana Perlaza Laurence Arowas Nathalie Jolly Sandrine Fernandes Pell Source Type: research

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.2100272.ABSTRACTFollowing the spread of the SARS-CoV-2 B.1.1.7 variant, social distancing was strengthened in France in January 2021. Using a two-strain mathematical model calibrated on genomic surveillance, we estimated that curfew measures allowed hospitalisations to plateau by decreasing transmission of the historical strains while B.1.1.7 continued to grow. School holidays appear to have further slowed down progression in February. Without progressively strengthened social distancing, a rapid surge of hospitalisations is expected, despite the foreseen...
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Laura Di Domenico Chiara E Sabbatini Giulia Pullano Daniel L évy-Bruhl Vittoria Colizza Source Type: research

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
ConclusionsIn a first continuous surveillance of CPE in Switzerland, we found that the epidemiological situation aggravated nationwide and that regional patterns of CPE genotypes mirrored the situation in neighbouring European countries.PMID:33860749 | DOI:10.2807/1560-7917.ES.2021.26.15.1900760 (Source: Euro Surveill)
Source: Euro Surveill - April 16, 2021 Category: Infectious Diseases Authors: Alban Ramette Michael Gasser Patrice Nordmann Reinhard Zbinden Jacques Schrenzel Damir Perisa Andreas Kronenberg Source Type: research